# The Effect of Adding Lubiprostone to Standard Large-Volume PEG-ELS on The Quality of Inpatient Colonoscopy Preparation

> **NCT04361656** · — · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Colonoscopy Preparation

## Interventions

- **DRUG:** PEG-ELS current standard of care
- **DRUG:** PEG-ELS current standard of care plus Lubiprostone 24 microgram Oral Cap (x2)

## Key facts

- **NCT ID:** NCT04361656
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-02-04
- **Final completion:** 2021-02-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Endoscopy services were suspended in March 2019 due to COVID-19 pandemic. Study was not restarted.
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361656, "The Effect of Adding Lubiprostone to Standard Large-Volume PEG-ELS on The Quality of Inpatient Colonoscopy Preparation". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04361656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*